WallStSmart

Accelerant Holdings (ARX)vsMarsh & McLennan Companies, Inc. (MRSH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Marsh & McLennan Companies, Inc. generates 2830% more annual revenue ($27.95B vs $953.90M). MRSH leads profitability with a 14.2% profit margin vs -150.6%. MRSH earns a higher WallStSmart Score of 62/100 (C+).

ARX

Avoid

34

out of 100

Grade: F

Growth: 7.3Profit: 2.5Value: 5.0Quality: 5.5
Piotroski: 5/9Altman Z: -0.52

MRSH

Buy

62

out of 100

Grade: C+

Growth: 6.0Profit: 8.0Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.74

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ARX2 strengths · Avg: 9.5/10
Revenue GrowthGrowth
59.7%10/10

Revenue surging 59.7% year-over-year

Debt/EquityHealth
0.179/10

Conservative balance sheet, low leverage

MRSH4 strengths · Avg: 8.5/10
Market CapQuality
$91.72B9/10

Large-cap with strong market position

Return on EquityProfitability
26.2%9/10

Every $100 of equity generates 26 in profit

Operating MarginProfitability
26.3%8/10

Strong operational efficiency at 26.3%

Free Cash FlowQuality
$1.45B8/10

Generating 1.5B in free cash flow

Areas to Watch

ARX4 concerns · Avg: 2.0/10
Return on EquityProfitability
-197.2%2/10

ROE of -197.2% — below average capital efficiency

EPS GrowthGrowth
-11.1%2/10

Earnings declined 11.1%

Free Cash FlowQuality
$-28.10M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
-0.522/10

Distress zone — elevated risk

MRSH3 concerns · Avg: 3.7/10
PEG RatioValuation
1.764/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.744/10

Distress zone — elevated risk

Debt/EquityHealth
1.473/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : ARX

The strongest argument for ARX centers on Revenue Growth, Debt/Equity. Revenue growth of 59.7% demonstrates continued momentum.

Bull Case : MRSH

The strongest argument for MRSH centers on Market Cap, Return on Equity, Operating Margin.

Bear Case : ARX

The primary concerns for ARX are Return on Equity, EPS Growth, Free Cash Flow.

Bear Case : MRSH

The primary concerns for MRSH are PEG Ratio, Altman Z-Score, Debt/Equity.

Key Dynamics to Monitor

ARX profiles as a hypergrowth stock while MRSH is a value play — different risk/reward profiles.

ARX is growing revenue faster at 59.7% — sustainability is the question.

MRSH generates stronger free cash flow (1.5B), providing more financial flexibility.

Monitor INSURANCE BROKERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MRSH scores higher overall (62/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accelerant Holdings

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Accelerant Holdings (ARX) is an innovative specialty insurance and reinsurance provider committed to serving underserved markets with a collaborative membership model. Utilizing advanced data analytics and cutting-edge technology, the company enhances underwriting performance and fosters innovation in risk management alongside its insurance partners. This strategic framework allows Accelerant to agilely adapt to the evolving insurance landscape, thereby positioning itself for sustained long-term growth anchored in operational excellence.

Visit Website →

Marsh & McLennan Companies, Inc.

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people globally. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?